TSX:CPH - Toronto Stock Exchange - CA17253X1050 - Common Stock - Currency: CAD
CPH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 34 industry peers in the Pharmaceuticals industry. While CPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CPH is growing strongly while it is still valued neutral. This is a good combination! This makes CPH very considerable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.67% | ||
ROE | 8.79% | ||
ROIC | 3.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 18.39% | ||
PM (TTM) | 23.4% | ||
GM | 71.95% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.38 | ||
Debt/FCF | N/A | ||
Altman-Z | 3.8 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.28 | ||
Quick Ratio | 1.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.71 | ||
Fwd PE | 13.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 20.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
TSX:CPH (6/13/2025, 7:00:00 PM)
13.09
-0.27 (-2.02%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.71 | ||
Fwd PE | 13.15 | ||
P/S | 6.23 | ||
P/FCF | N/A | ||
P/OCF | 11.53 | ||
P/B | 2.34 | ||
P/tB | 22.82 | ||
EV/EBITDA | 20.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.67% | ||
ROE | 8.79% | ||
ROCE | 4.99% | ||
ROIC | 3.6% | ||
ROICexc | 4.24% | ||
ROICexgc | 18.03% | ||
OM | 18.39% | ||
PM (TTM) | 23.4% | ||
GM | 71.95% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.38 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 3.14 | ||
Cap/Depr | 1442.16% | ||
Cap/Sales | 202.56% | ||
Interest Coverage | 250 | ||
Cash Conversion | 166.44% | ||
Profit Quality | N/A | ||
Current Ratio | 2.28 | ||
Quick Ratio | 1.97 | ||
Altman-Z | 3.8 |